Insulin-like growth factor binding protein 1 (IGFBP-1) is a potentially interesting marker for liver fat in NAFLD as it is exclusively produced by the liver, and insulin is its main regulator. Here, IGFBP1 is linked to metabolic dysfunction-associated steatotic liver disease.